Table 4.

Final dose of ketoconazole used in patients with Cushing’s disease.

Final dose	Controlled/partially controlled	Uncontrolled
≤100 mg	1 (4%)	0
200 mg	2 (8%)	0
300 mg	0	1 (12.5%)
400 mg	6 (24%)	2 (25%)
600 mg	9 (36%)	3 (37.5%)
800 mg	6 (24%)	2 (25%)
1,000 mg	1 (4%)	0